Home › Funds › BOONE CAPITAL MANAGEMENT LLC › MIRM

BOONE CAPITAL MANAGEMENT LLC position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

BOONE CAPITAL MANAGEMENT LLC reported holding 415,641 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$48.7M, representing 11.38% of its reported portfolio and ranking #2 among its reported holdings. BOONE CAPITAL MANAGEMENT LLC has disclosed MIRM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)415.64K sh
Reported value held$48.66M
Portfolio Weight11.38%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BOONE CAPITAL MANAGEMENT LLC's MIRM position evolved

BOONE CAPITAL MANAGEMENT LLC first disclosed a stake in MIRM in Q3 2023 at 389,791 shares (US$12.3M). The position peaked in Q2 2026 at 415,641 shares, worth US$48.7M. Across 12 filings, BOONE CAPITAL MANAGEMENT LLC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 415,641 shares valued at US$48.7M — a reduction of -5,595 shares quarter over quarter.. Notable position changes include a 26% increase in Q4 2023 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 389.79K $12.32M New
Q4 2023 490.14K $14.47M Add
Q1 2024 451.90K $11.35M Reduce
Q2 2024 523.68K $17.90M Add
Q3 2024 543.84K $21.21M Add
Q4 2024 581.84K $24.06M Add
Q1 2025 603.32K $27.18M Add
Q2 2025 641.45K $32.64M Add
Q3 2025 535.73K $39.27M Reduce
Q4 2025 421.24K $33.27M Reduce
Q1 2026 421.24K $38.91M Hold
Q2 2026 415.64K $48.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 61 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has BOONE CAPITAL MANAGEMENT LLC held MIRM?

BOONE CAPITAL MANAGEMENT LLC has disclosed MIRM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BOONE CAPITAL MANAGEMENT LLC's current position in MIRM?

As of Q2 2026, BOONE CAPITAL MANAGEMENT LLC holds 415.64K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $48.66M, representing 11.38% of its reported portfolio and ranking #2.

Has BOONE CAPITAL MANAGEMENT LLC been buying or selling MIRM?

In the latest 13F filing (Q2 2026), BOONE CAPITAL MANAGEMENT LLC reduced its position in MIRM. The position peaked in Q2 2026 at 415.64K shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.